NVS Jan 2024 87.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.5900

0.0000

(0.00%)

As of 03:55PM EST. Market open.

Loading interactive chart…

Zacks
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
AbbVie (ABBV) offers to acquire cancer biotech Immunogen for $10.1 billion. Novartis (NVS) raises its mid-term sales growth outlook by 1%.
Insider Monkey
25 Most Expensive Countries in the World to Raise a Child
In this article, we will look into the 25 most expensive countries in the world to raise a child. If you want to skip our detailed analysis, you can go directly to the 5 Most Expensive Countries in the World to Raise a Child. Cost of Raising a Child According to a report by The […]
Zacks
Why Is Pfizer (PFE) Down 1.4% Since Last Earnings Report?
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.